Skip to main content
  • Crushing Ticagrelor Makes No Difference in Platelet Activity for PCI Patients Receiving Fentanyl

    Crushing ticagrelor made no significant differences in platelet reactivity when administered with fentanyl to patients undergoing percutaneous coronary intervention (PCI) in the single-center FACT PCI trial. 

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details